A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2168-4804
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators ; day:3 ; month:6 ; year:2022 ; pages:1-27
Therapeutic innovation & regulatory science ; (3.6.2022), 1-27
- Urheber
-
Garashi, Hamza Y.
Steinke, Douglas T.
Schafheutle, Ellen I.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s43441-022-00415-y
- URN
-
urn:nbn:de:101:1-2022080222442528662713
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Garashi, Hamza Y.
- Steinke, Douglas T.
- Schafheutle, Ellen I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Brodalumab: 5-Year US Pharmacovigilance Report
Drug-associated porphyria: a pharmacovigilance study
Big data, medicines safety and pharmacovigilance
Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Brodalumab: 5-Year US Pharmacovigilance Report
Drug-associated porphyria: a pharmacovigilance study
Big data, medicines safety and pharmacovigilance
Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
Pharmacovigilance in oncology
Algorithmovigilance, lessons from pharmacovigilance
Towards robust pharmacovigilance surveillance systems
An historical overview over Pharmacovigilance
Pharmacoenvironmentology – a component of pharmacovigilance
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance
Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
Brodalumab: 5-Year US Pharmacovigilance Report
Drug-associated porphyria: a pharmacovigilance study